Project cooperationUpdated on 19 January 2026
Nanomaterial-Enhanced Rapid Molecular Diagnostics for Emerging Infectious Diseases
Postdoctoral Research Fellow at FORTH, Biosensors lab
Heraklion, Greece
About
We are seeking to participate in a Horizon Europe project consortium focused on developing rapid, sensitive, and portable molecular diagnostic tools for emerging and high-priority infectious diseases. Our work centres on combining isothermal nucleic acid amplification with nanomaterial-enabled detection, particularly using functionalised nanoparticles/nanoclusters for fluorescence or colourimetric signal generation.
Our team offers strong expertise in:
-
LAMP assay design and optimisation for pathogen detection
-
Nanoparticle/nanocluster-based sensing and signal amplification
-
Integration of nanomaterials into molecular diagnostic workflows
-
Development of rapid, low-cost, user-friendly detection systems suitable for point-of-care and decentralised use
We welcome collaboration with academic groups, clinical partners, SMEs, and industry interested in advancing innovative diagnostic solutions aligned with Horizon Europe priorities in infectious disease detection, pandemic preparedness, and accessible point-of-care technologies.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
yannick guari
Researcher at CNRS
Montpellier, France
Project cooperation
Integrated Omics–Driven Diagnostic Innovation Laboratory
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vel Murugan
Professor at AZ Board of Regents on behalf of Arizona State University
Tempe, United States
Project cooperation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Silvia Angeletti
Full Professor Clinical Pathology and Head of Laboratory Unit at Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy